Twist Custom Panels for NGS Applications

Twist custom panels are highly customisable solutions, allowing the exact selection of regions, genes, pathways or variants of interest. They are designed to offer high performance, flexibility and precision in all types of applications and starting samples.

Detailed Description

Operating principle:

In practice, the use of custom panels makes it possible to overcome the limitations of standard panels, giving the laboratory complete control over which regions to sequence and allowing the design of panels adapted to specific biological questions, avoiding generic approaches and enabling the analysis to focus on specific genes, pathways, variants or regions.

To achieve this, Twist technology combines proprietary chemistry for the design of double-stranded DNA (dsDNA) probes with its capture enrichment solution, ensuring high quality and optimal panel performance in DNA and RNA applications and even methylation studies.

The design and quality controls of the probes (performed by NGS) are optimised to ensure an exceptional coverage uniformity rate, high reproducibility and a high on-target ratio regardless of panel size. With all this, Twist chemistry maximises sequencing efficiency, making the most of each laboratory’s resources.

In addition, the modularity of Twist reagents makes it possible to adapt the use of these custom panels to any type of application in both germline and somatic contexts. From good-quality DNA and RNA samples obtained from sources such as whole blood to complex samples such as cfDNA or those obtained from paraffin-embedded tissue.

Benefits

Exceptional performance: high coverage uniformity, on-target ratio and reproducibility, allowing you to get the most out of your assays. Optimisation of sequencing costs for more efficient use of resources Simple and agile customisation with support throughout the entire process. Versatility of applications and sample types: germline/somatic, DNA/RNA/cfDNA, blood/FF/FFPE. Automation available on different systems (Hamilton, Revvity, etc)
Image 1

Technology used:

The Twist design platform incorporates different approaches depending on the type of application:

DNA: custom targeted enrichment panels for obtaining specific genomic data. It includes strategies such as probe shifter technology to improve design performance and precision, or different tiling strategies to optimise the capture of complex regions or alterations.
RNA: custom panels for capturing transcriptomic data from libraries converted to cDNA. The design uses strategies such as exon-aware placement to promote the capture of isoforms, fusions and complex exons.
Methylation: custom methylated DNA panels with a design that includes four probe species per target: fully methylated, fully unmethylated, sense and antisense, with the aim of preserving methylation pattern information and maintaining high uniformity.
Image 2
Image 3
Image 4

Intended audience/user:

Solution intended for laboratories and research teams that need to design custom NGS panels to answer specific questions in DNA, RNA or methylation studies. It is especially intended for users who require flexibility in target selection, high capture performance and efficient use of sequencing.

Intended use for microbiology:

Viruses: Whole-genome sequencing of pathogens from primary samples. Epidemiological surveillance. Antiviral resistance. Targeted metagenomics

Bacteria: genomic surveillance. Whole-genome sequencing of pathogens from primary samples. Antimicrobial resistance. Targeted metagenomics, typing and molecular epidemiology

Key Aspects

Complete control over the targets to be studied and agile panel customisation according to specific genes, pathways or variants.
High-performance enrichment for DNA, RNA and methylation.
Uniform coverage and a high on-target proportion, even in GC-rich and complex regions. Uniform and reproducible data that reduce revalidation.
Capture of isoforms, fusions and difficult-to-access exons. Detection of rare variants, CNVs and low-frequency events.
Cost optimisation by avoiding unnecessary sequencing excess and oversized approaches.
Automation
Versatility in applications and sample types.
Design and guidance from an expert support group.

Presentation Details

Available in a 96-reaction format

Area:

Bacteria, Clonality Studies, Hereditary and/or Rare Diseases, Lymphoid line, Microbiology, Minimal residual disease, Molecular Genetics, Myeloid line, Oncohematology, Targeted study of specific pathologies, Virus
Consult our experts

Google reCaptcha: Invalid site key.

Related products

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
Next Generation Sequencing (NGS)

SeqOne HRD Solution con Agilent SureSelect CD HRR17 Panel

HRD analysis solution combining low-coverage whole-genome sequencing (shallow/low-pass WGS) and a targeted gene panel to detect genomic instability, BRCA1/2 alterations and other genes related to homologous recombination. It is designed for laboratories wishing to implement HRD testing in-house with an automated, efficient and clinically validated workflow. Detailed Description SeqOne’s HRD solution combines shallow WGS and…
Agilent
Next Generation Sequencing (NGS)

OncoSELECT®

Comprehensive targeted liquid biopsy assay designed to support decision-making in oncology through the analysis of 74 clinically relevant genes. The solution encompasses everything from library preparation reagents to bioinformatics analysis, clinical interpretation and the generation of detailed reports. 3.- Detailed Description Operating principle OncoSELECT® is an advanced liquid biopsy panel based on circulating cell-free DNA…
OncoDNA
Next Generation Sequencing (NGS)

Agilent SureSelect Human All Exon V8.

High-performance exome for the enrichment of human coding regions, with updated coverage of RefSeq, CCDS and GENCODE, including the TERT promoter and difficult-to-capture exons. 3.- Detailed Description Operating principle SureSelect Human All Exon V8 is based on NGS library preparation and capture enrichment of target regions of the human exome. The workflow is compatible with…
Agilent
Next Generation Sequencing (NGS)